NSCLC
Conditions
Interventions
Gold Standard:1. Comparable product
2. Sequencing method
to 
be 
evaluated.
Cancer 
gene 
data 
analysis 
software.
Manufacturer: 
burnstone 
co. 
LTD
Model: 
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: This clinical trial mainly selected patients diagnosed with non-small cell lung cancer (NSCLC) based on pathology. At the same time, some benign lung tumors were also selected to serve as interference samples. The gender and age of the patients are not limited. Inclusion criteria: 1. Pathological diagnosis of non-small cell lung cancer (NSCLC); 2. Pathological diagnosis of small cell lung cancer; 3. The pathologic diagnosis was benign lung tumor.
Exclusion criteria
Exclusion criteria: (1) At the time of enrollment, samples must a minimum of 24 months of retention time; (2) tissue samples cannot meet the requirements of detection (for example, insufficient samples of paraffin blocks, loss of paraffin blocks, etc.); (3) repeated sampling of the same case; (4) the number of cases exceeded (competition for enrollment); (5) incomplete and non-standard sample information.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lung tumor gene;SEN, SPE, ACC, AUC of ROC; | — |
Countries
China
Contacts
Public ContactTang Yuan
West China Hospital, Sichuan University
Outcome results
None listed